Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial-Reference-Cited by-同舟云学术

Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial

Published:2013-09 Issue:3 Volume:166 Page:435-441.e2
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Kimmel Stephen E.,French Benjamin,Anderson Jeffrey L.,Gage Brian F.,Johnson Julie A.,Rosenberg Yves D.,Geller Nancy L.,Kasner Scott E.,Eby Charles S.,Joo Jungnam,Caldwell Michael D.,Goldhaber Samuel Z.,Hart Robert G.,Cifelli Denise,Madigan Rosemary,Brensinger Colleen M.,Goldberg Suzanne,Califf Robert M.,Ellenberg Jonas H.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. Incidence and preventability of adverse drug events among older persons in the ambulatory setting;Gurwitz;JAMA,2003

2. Emergency hospitalizations for adverse drug events in older Americans;Budnitz;N Engl J Med,2011

3. Hemorrhagic complications of anticoagulant treatment;Levine;Chest,1998

4. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation;Hylek;N Engl J Med,1996

5. Audit of the frequency and clinical response to excessive oral anticoagulation in an out-patient population;Brigden;Am J Hematol,1998

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reactive, Point-of-Care, Preemptive, and Direct-to-Consumer Pharmacogenomics Testing;Pharmacogenomics;2019

2. PHARMACOGENETIC CONSIDERATIONS OF ANTICOAGULANT MEDICATION;J PHYSIOL PHARMACOL;2018

3. Warfarin: The End or the End of One Size Fits All Therapy?;Journal of Personalized Medicine;2018-06-28

4. Pharmacogenetics;Principles and Applications of Molecular Diagnostics;2018

5. Designing Genetic- and Genomic-Based Clinical Trials;Genomic and Precision Medicine;2017